TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced August 3, 1990
TCL Archive NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer May 1, 1981